Background reading on how these compounds are studied. This page is not dosing guidance, and it does not link to products.
Peptides are short chains of amino acids that act as signaling molecules. In research settings they are studied for how they interact with specific receptors and pathways: metabolic and growth-hormone signaling, tissue repair, cognition, and cellular aging.
The compounds studied today cluster into a handful of families by mechanism:
5-Amino-1MQ, AOD-9604, Retatrutide, MOTS-c
MOTS-c, NAD+, SS-31, Vitamin B12
GLOW, KLOW, Selank + Semax, Wolverine
BPC-157, GHK-Cu, KPV, TB-500
Glutathione, Thymosin Alpha-1, KPV
CJC-1295 + Ipamorelin, Ipamorelin, Tesamorelin
DSIP, Selank, Semax
Epithalon, Melatonin, Pinealon, Glutathione, Thymosin Alpha-1
HCG, Kisspeptin-10, Melanotan I, Melanotan II, PT-141
AHK-Cu, SNAP-8, GHK-Cu
Evidence quality varies enormously across this space. A few compounds, like the GLP-1 receptor agonists, have large human trials behind them. Many others rest on animal studies, cell work, or community observation. Good research reading keeps that hierarchy in view: a Phase 3 trial and a forum report are not the same kind of fact.
Most peptides ship lyophilized because the dry powder is far more stable than the compound in solution. Once reconstituted, potency runs on a clock set by the peptide's structure, temperature and light exposure. Copper peptides oxidize, fragile sequences degrade within weeks, and a few small molecules hold far longer. Storage specifics vary by compound.
This library summarizes published third-party research for educational context only. It is not medical advice, not a recommendation, and not a claim about any product.